Violin Jonathan Insider Trades

Insider Trading History

Track insider trading activity for Violin Jonathan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Catalyst Biosciences
Catalyst Biosciences CBIO
Director
Holding Value $193k 11,050 shares
Last Trade
Jun 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$188k 11,050 shares
$17.01
$17.50
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $533k 6,090 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$546k 6,090 shares
$89.63
$87.53
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.31M 263,321 shares
$12.58
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $0 0 shares
Last Trade
Jan 23, 2026 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$972k 77,249 shares
$12.58
$12.58
Catalyst Biosciences
Catalyst Biosciences CBIO
Director
Holding Value $158k 9,023 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$138k 9,023 shares
$15.30
$17.50
Catalyst Biosciences
Catalyst Biosciences CBIO
Director
Holding Value $1.22M 69,515 shares
Last Trade
Jun 13, 2025 Sale
$3.63M 226,786 shares
$16.00
$17.50
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $334k 26,550 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$154k 26,550 shares
$5.79
$12.58
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $1.09M 12,500 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 12,500 shares
$18.36
$87.53
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $177k 14,100 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 14,100 shares
$9.18
$12.58
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $963k 11,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 11,000 shares
$21.77
$87.53
Magenta Therapeutics
Magenta Therapeutics MGTA
Director
Holding Value $4.55k 6,500 shares
Last Trade
Sep 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.55k 6,500 shares
$0.70
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $569k 6,500 shares
Last Trade
Sep 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.55k 6,500 shares
$0.70
$87.53
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $177k 14,100 shares
Last Trade
Jun 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 14,100 shares
$11.35
$12.58
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Executive Officer
Holding Value $9.17M 530,905 shares
Last Trade
Feb 02, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.85M 50,000 shares
$37.09
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Executive Officer
Holding Value $7.45M 430,905 shares
Last Trade
Feb 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.84M 50,000 shares
$36.80
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Executive Officer
Holding Value $8.31M 480,905 shares
Last Trade
Feb 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.84M 50,000 shares
$36.80
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Executive Officer
Holding Value $4.13M 239,205 shares
Last Trade
Feb 02, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.85M 50,000 shares
$37.09
$17.28
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $105k 8,333 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 8,333 shares
$3.00
$12.58
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $105k 8,333 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50k 16,666 shares
$3.00
$12.58
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Executive Officer
Holding Value $8.31M 480,905 shares
Last Trade
Jun 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$366k 30,000 shares
$12.20
$17.28

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up